Nov 13 (Reuters) - Mersana Therapeutics Inc MRSN.O:
MERSANA THERAPEUTICS PROVIDES BUSINESS UPDATE AND ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS
MERSANA THERAPEUTICS: CASH, CASH EQUIVALENTS & MARKETABLE SECURITIES AS OF SEPTEMBER 30, 2024, WERE $155.2 MILLION
Source text: nGNXbJTT8g
Further company coverage: MRSN.O
((Reuters.Briefs@thomsonreuters.com;))